Search

Author/Creator Bono, Marco

1. BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients. (December 2020)

Authors:
Incorvaia, Lorena; Fanale, Daniele; Bono, Marco; Calò, Valentina; Fiorino, Alessia; Brando, Chiara; Corsini, Lidia Rita; Cutaia, Sofia; Cancelliere, Daniela; Pivetti, Alessia; Filorizzo, Clarissa; La Mantia, Maria; Barraco, Nadia; Cusenza, Stefania; Badalamenti, Giuseppe; Russo, Antonio; Bazan, V...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning. (April 2022)

Authors:
Fanale, Daniele; Pivetti, Alessia; Cancelliere, Daniela; Spera, Antonio; Bono, Marco; Fiorino, Alessia; Pedone, Erika; Barraco, Nadia; Brando, Chiara; Perez, Alessandro; Guarneri, Maria Francesca; Russo, Tancredi Didier Bazan; Vieni, Salvatore; Guarneri, Girolamo; Russo, Antonio; Bazan, Viviana
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 172(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. (February 2022)

Authors:
Fanale, Daniele; Corsini, Lidia Rita; Scalia, Raimondo; Brando, Chiara; Cucinella, Alessandra; Madonia, Giorgio; Dimino, Alessandra; Filorizzo, Clarissa; Barraco, Nadia; Bono, Marco; Fiorino, Alessia; Magrin, Luigi; Sciacchitano, Roberta; Perez, Alessandro; Russo, Tancredi Didier Bazan; Pantuso, ...
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 170(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs). (September 2021)

Authors:
Incorvaia, Lorena; Badalamenti, Giuseppe; Fanale, Daniele; Vincenzi, Bruno; Luca, Ida De; Algeri, Laura; Barraco, Nadia; Brando, Chiara; Bonasera, Annalisa; Bono, Marco; Castiglia, Marta; Cancelliere, Daniela; Cani, Massimiliano; Rita Corsini, Lidia; Fiorino, Alessia; Galvano, Antonio; Pedone, Er...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗